Clinical Simulation-based Usability Testing of a Mobile Telestroke System (P3.104)

Conclusions:Our study shows the feasibility and capability of a mobile telestroke system to accurately assess actors simulating stroke patients during transport.Study Supported by: Virginia Commonwealth University (VCU) Dean’s Enhancement Award, VCU CTSA (UL1TR000058) from the National Center for Advancing Sciences, CCTR Endowment Fund of Virginia Commonwealth University (VCU)Disclosure: Dr. Heath has nothing to disclose. Dr. Mehndiratta has nothing to disclose. Dr. Decker has nothing to disclose. Dr. Lawrence has nothing to disclose. Dr. Whitt has nothing to disclose. Dr. Fellows has nothing to disclose. Dr. Broadnax has nothing to disclose. Dr. Lavrentyev has nothing to disclose. Dr. Feldman has nothing to disclose. Dr. Henry has nothing to disclose. Dr. Wong has nothing to disclose. Dr. Ruiz has nothing to disclose. Dr. Hekmatodoost has nothing to disclose. Dr. Ono has nothing to disclose. Dr. Bhatti has nothing to disclose. Dr. Rahim has nothing to disclose. Dr. Toqeer has nothing to disclose. Dr. Ricks has nothing to disclose. Dr. Madu has nothing to disclose. Dr. Blankson has nothing to disclose. Dr. Heath has nothing to disclose. Dr. Brown has nothing to disclose. Dr. Bennam has nothing to disclose. Dr. Lu has nothing to disclose. Dr. Felton has received compensation from Biogen Idec, Teva, Bristol-Myers Squibb, Serono, Sanofi-Aventis and Pfizer for speaking. Dr. Felton has received research support from the following organizations: NIH (WARCEF), Merck (MERCK), N...
Source: Neurology - Category: Neurology Authors: Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research